KMT5B and cancer: Among its 32 target genes, 10 (including TIMP4, BCAT1, PDIA3, SUV420H1, HSP90B1, MTHFD2, STAMBP, CANX, TMEM14C, and SLC22A15) correlate with 5-year survival, likely by modulating cancer cell metastasis [44].